Companies/JP/4553

TOWA PHARMACEUTICAL CO., LTD. · 東和薬品株式会社

Income flow

Annual
4553 ANNUAL Income StatementPeriod 2026-03-31Source ANNUAL
Services & otherJPY 216BOverseasJPY 58BRevenueJPY 274B+5% Y/YGross profitJPY 99B+5% Y/YCost of revenueJPY 175BOperating profitJPY 23B-1% Y/YOperating expensesJPY 76BNet profitJPY 5B-72% Y/YTaxJPY 8BSG&AJPY 76BR&D & otherJPY 1M

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Revenue mix

2026-03-31 · ANNUAL · JPY
By activity
By activityJPY 57.6B
  • OverseasJPY 57.6B100.0%
By geography
By geographyJPY 217.0B
  • DomesticJPY 217.0B100.0%

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).2.23%5y avgAverage dividend yield over the past five years — a smoother view than the latest print.2.24%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).80PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.47.6%Shares outTotal shares currently outstanding (issued and not retired).49.2MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).23.0M
Upcoming dividend
Next ex-div
2027-03-30 · declared
Last cash
45 · 2027-03-30
Stock splits
  1. 3:12019-03-27